Analysis the alpha-protein level in hepatitis patient as an aid in accessing the degree in which it generates to hcc

Thesis Abstract

Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with chronic hepatitis B and C infections being significant risk factors for its development. Alpha-fetoprotein (AFP) is a well-established biomarker used in the surveillance and diagnosis of HCC. However, its role in predicting the progression of HCC from chronic hepatitis has been a topic of debate. This research project aims to analyze the levels of alpha-fetoprotein in hepatitis patients to assess its utility in predicting the development of HCC. The study will involve a cohort of hepatitis patients with varying degrees of liver disease progression, including those with cirrhosis and early-stage HCC. Blood samples will be collected from these patients at regular intervals, and AFP levels will be measured using standardized laboratory techniques. The data obtained from this study will be analyzed to determine the correlation between AFP levels and the progression to HCC in hepatitis patients. Statistical methods will be employed to assess the sensitivity, specificity, and predictive value of AFP as a biomarker for HCC development. Additionally, the study will investigate whether other factors, such as patient demographics and liver function tests, influence the predictive ability of AFP. The results of this research will provide valuable insights into the role of AFP in monitoring hepatitis patients for the development of HCC. If AFP levels are found to correlate significantly with HCC progression, it could serve as a useful tool in identifying high-risk patients who may benefit from closer surveillance or early intervention. Conversely, if AFP is not a reliable predictor of HCC development, alternative biomarkers or imaging modalities may need to be explored. Overall, this study has the potential to improve the management of hepatitis patients at risk of developing HCC by providing clinicians with a better understanding of the value of AFP monitoring. By elucidating the relationship between AFP levels and HCC progression, this research may contribute to more personalized and effective strategies for detecting and managing liver cancer in high-risk populations.